Castle Biosciences Shares Rise 11% on Discovering Data for Potential Complementary Tests

By Denny Jacob Castle Biosciences shares rose 11% to $18.40 after disclosing new discovery data from an ongoing study exploring the potential for a...

Related Keywords

Robert Cook ,Denny Jacob ,Castle Biosciences , ,Article Normal ,Medical Equipment Supplies ,Healthcare Life Sciences ,Medical Devices Apparatus ,Diagnostic Therapeutic Devices ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,Synd ,Cstl ,Commodity ,Financial Market News ,Medical Equipment ,Supplies ,Healthcare ,Life Sciences ,Medical Devices ,Apparatus ,Diagnostic ,Therapeutic Devices ,